These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10765033)

  • 1. Comparative in vitro activity of S-4661, a new parenteral carbapenem, and other antimicrobial agents against respiratory pathogens.
    Watanabe A; Takahashi H; Kikuchi T; Kobayashi T; Gomi K; Fujimura S; Tokue Y; Nukiwa T
    Chemotherapy; 2000; 46(3):184-7. PubMed ID: 10765033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidine against clinical isolates from West Germany.
    Bauernfeind A; Jungwirth R; Schweighart S
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():73-84. PubMed ID: 2509418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations.
    Jones RN; Huynh HK; Biedenbach DJ; Fritsche TR; Sader HS
    J Antimicrob Chemother; 2004 Jul; 54(1):144-54. PubMed ID: 15190031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antibacterial activity of S-4661, a new parenteral carbapenem, against urological pathogens isolated from patients with complicated urinary tract infections.
    Nomura S; Nagayama A
    J Chemother; 2002 Apr; 14(2):155-60. PubMed ID: 12017370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro activity of biapenem (BIPM) against clinically isolated respiratory pathogens in 1996-1998].
    Watanabe A; Tokue Y; Takahashi H; Kikuchi T; Kobayashi T; Gomi K; Fujimura S; Yasui S; Nukiwa T; Shoji S; Honda Y
    Jpn J Antibiot; 1999 Dec; 52(12):690-4. PubMed ID: 10695024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial properties of BO-2727, a new carbapenem antibiotic.
    Kato Y; Otsuki M; Nishino T
    J Antimicrob Chemother; 1997 Aug; 40(2):195-203. PubMed ID: 9301984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of a new carbapenem antibiotic, BO-2727, with potent antipseudomonal activity.
    Nakagawa S; Hashizume T; Matsuda K; Sanada M; Okamoto O; Fukatsu H; Tanaka N
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2756-9. PubMed ID: 8109950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preclinical evaluation of meropenem, a new parenteral carbapenem].
    Edwards JR
    New Microbiol; 1995 Oct; 18 Suppl():19S-31S. PubMed ID: 8574929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of meropenem versus other extended-spectrum antimicrobials against randomly chosen and selected resistant clinical isolates tested in 26 North American centers.
    Pitkin DH; Sheikh W; Nadler HL
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S238-48. PubMed ID: 9126699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in-vitro activity of carbapenem antibiotics against respiratory pathogens isolated between 1999 and 2000.
    Watanabe A; Tokue Y; Takahashi H; Kikuchi T; Kobayashi T; Gomi K; Fujimura S; Yasui S; Murayama Y; Nukiwa T
    J Infect Chemother; 2001 Dec; 7(4):267-71. PubMed ID: 11810597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem.
    Koga T; Abe T; Inoue H; Takenouchi T; Kitayama A; Yoshida T; Masuda N; Sugihara C; Kakuta M; Nakagawa M; Shibayama T; Matsushita Y; Hirota T; Ohya S; Utsui Y; Fukuoka T; Kuwahara S
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3239-50. PubMed ID: 16048932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity of doripenem and other carbapenems against gram-negative pathogens from Korea.
    Lee H; Ko KS; Song JH; Peck KR
    Microb Drug Resist; 2011 Mar; 17(1):37-45. PubMed ID: 20950191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study.
    Kiratisin P; Chongthaleong A; Tan TY; Lagamayo E; Roberts S; Garcia J; Davies T
    Int J Antimicrob Agents; 2012 Apr; 39(4):311-6. PubMed ID: 22386743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo antibacterial activities of meropenem, a new carbapenem antibiotic.
    Harabe E; Kawai Y; Kanazawa K; Otsuki M; Nishino T
    Drugs Exp Clin Res; 1992; 18(2):37-46. PubMed ID: 1644010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).
    Fritsche TR; Stilwell MG; Jones RN
    Clin Microbiol Infect; 2005 Dec; 11(12):974-84. PubMed ID: 16307551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of in vitro activity of new fluoroquinolones, cephalosporins and carbapenems against 569 gram-negative bacteria].
    Gales AC; Pignatari AC; Jones RN; Baretta M; Sader HS
    Rev Assoc Med Bras (1992); 1997; 43(2):137-44. PubMed ID: 9336049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antimicrobial susceptibilities of organisms isolated from patients with urinary tract infections in 2002].
    Eta S; Kawahara M
    Jpn J Antibiot; 2006 Feb; 59(1):21-8. PubMed ID: 16673579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity of carbapenems against clinical isolates of respiratory bacterial pathogens in the northeastern region of Japan in 2007.
    Gomi K; Fujimura S; Fuse K; Takane H; Nakano Y; Kariya Y; Kikuchi T; Kurokawa I; Tokue Y; Watanabe A
    J Infect Chemother; 2011 Apr; 17(2):200-6. PubMed ID: 20839026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial Susceptibility among European Gram-Negative and Gram-Positive Isolates Collected as Part of the Tigecycline Evaluation and Surveillance Trial (2004-2014).
    Rodloff AC; Dowzicky MJ
    Chemotherapy; 2017; 62(1):1-11. PubMed ID: 27216271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.